Literature DB >> 25961940

The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia.

Kajsa Paulsson1, Henrik Lilljebjörn1, Andrea Biloglav1, Linda Olsson1, Marianne Rissler1, Anders Castor2, Gisela Barbany3, Linda Fogelstrand4, Ann Nordgren3, Helene Sjögren5, Thoas Fioretos6, Bertil Johansson6.   

Abstract

High hyperdiploid (51-67 chromosomes) acute lymphoblastic leukemia (ALL) is one of the most common childhood malignancies, comprising 30% of all pediatric B cell-precursor ALL. Its characteristic genetic feature is the nonrandom gain of chromosomes X, 4, 6, 10, 14, 17, 18 and 21, with individual trisomies or tetrasomies being seen in over 75% of cases, but the pathogenesis remains poorly understood. We performed whole-genome sequencing (WGS) (n = 16) and/or whole-exome sequencing (WES) (n = 39) of diagnostic and remission samples from 51 cases of high hyperdiploid ALL to further define the genomic landscape of this malignancy. The majority of cases showed involvement of the RTK-RAS pathway and of histone modifiers. No recurrent fusion gene-forming rearrangement was found, and an analysis of mutations on trisomic chromosomes indicated that the chromosomal gains were early events, strengthening the notion that the high hyperdiploid pattern is the main driver event in this common pediatric malignancy.

Entities:  

Mesh:

Year:  2015        PMID: 25961940     DOI: 10.1038/ng.3301

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  70 in total

1.  TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children.

Authors:  Maoxiang Qian; Xueyuan Cao; Meenakshi Devidas; Wenjian Yang; Cheng Cheng; Yunfeng Dai; Andrew Carroll; Nyla A Heerema; Hui Zhang; Takaya Moriyama; Julie M Gastier-Foster; Heng Xu; Elizabeth Raetz; Eric Larsen; Naomi Winick; W Paul Bowman; Paul L Martin; Elaine R Mardis; Robert Fulton; Gerard Zambetti; Michael Borowitz; Brent Wood; Kim E Nichols; William L Carroll; Ching-Hon Pui; Charles G Mullighan; William E Evans; Stephen P Hunger; Mary V Relling; Mignon L Loh; Jun J Yang
Journal:  J Clin Oncol       Date:  2018-01-04       Impact factor: 44.544

Review 2.  Genetics and prognosis of ALL in children vs adults.

Authors:  Kathryn G Roberts
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 3.  How advanced are we in targeting novel subtypes of ALL?

Authors:  Charles G Mullighan
Journal:  Best Pract Res Clin Haematol       Date:  2019-10-18       Impact factor: 3.020

4.  High hyperdiploid childhood acute lymphoblastic leukemia: Chromosomal gains as the main driver event.

Authors:  Kajsa Paulsson
Journal:  Mol Cell Oncol       Date:  2015-07-06

5.  Deletions in BCP-ALL result in a TAD more FLT3.

Authors:  David H Spencer
Journal:  Blood       Date:  2020-08-20       Impact factor: 22.113

6.  Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia.

Authors:  Ling-Wen Ding; Qiao-Yang Sun; Kar-Tong Tan; Wenwen Chien; Anand Mayakonda; Allen Eng Juh Yeoh; Norihiko Kawamata; Yasunobu Nagata; Jin-Fen Xiao; Xin-Yi Loh; De-Chen Lin; Manoj Garg; Yan-Yi Jiang; Liang Xu; Su-Lin Lim; Li-Zhen Liu; Vikas Madan; Masashi Sanada; Lucia Torres Fernández; S S Hema Preethi; Michael Lill; Hagop M Kantarjian; Steven M Kornblau; Satoru Miyano; Der-Cherng Liang; Seishi Ogawa; Lee-Yung Shih; Henry Yang; H Phillip Koeffler
Journal:  Cancer Res       Date:  2016-11-21       Impact factor: 12.701

Review 7.  Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics.

Authors:  Sarah K Tasian; Stephen P Hunger
Journal:  Br J Haematol       Date:  2016-12-16       Impact factor: 6.998

Review 8.  Emerging Roles of GLI-Similar Krüppel-like Zinc Finger Transcription Factors in Leukemia and Other Cancers.

Authors:  Anton M Jetten
Journal:  Trends Cancer       Date:  2019-08-20

9.  A germ-line deletion of APOBEC3B does not contribute to subtype-specific childhood acute lymphoblastic leukemia etiology.

Authors:  Amelia D Wallace; Stephen S Francis; Xiaorong Shao; Adam J de Smith; Kyle M Walsh; Roberta Mckean-Cowdin; Xiaomei Ma; Gary Dahl; Lisa F Barcellos; Joseph L Wiemels; Catherine Metayer
Journal:  Haematologica       Date:  2017-10-12       Impact factor: 9.941

10.  Pediatric ALL relapses after allo-SCT show high individuality, clonal dynamics, selective pressure, and druggable targets.

Authors:  Jessica I Hoell; Sebastian Ginzel; Michaela Kuhlen; Andreas Kloetgen; Michael Gombert; Ute Fischer; Daniel Hein; Salih Demir; Martin Stanulla; Martin Schrappe; Udo Zur Stadt; Peter Bader; Florian Babor; Friedhelm Schuster; Brigitte Strahm; Julia Alten; Anja Moericke; Gabriele Escherich; Arend von Stackelberg; Ralf Thiele; Alice C McHardy; Christina Peters; Beat Bornhauser; Jean-Pierre Bourquin; Stefan Krause; Juergen Enczmann; Lüder Hinrich Meyer; Cornelia Eckert; Arndt Borkhardt; Roland Meisel
Journal:  Blood Adv       Date:  2019-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.